- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03670108
"SMS - Heals My Health"
September 12, 2018 updated by: Serge Perrot, Hôpital Cochin
Impact of Personalized SMS in Relay of Therapeutic Education Programs to Improve the Physical Activity of Patients in Rheumatology
Therapeutic patient education is an approach that has shown its usefulness in rheumatology, but the duration of its impact is limited, and therapeutic revisions are regularly necessary.
The practice of physical activity is one of the goals of TPE in rheumatology and new technologies, such as SMS messages represent a possible complementary tool to amplify behavioral changes The study primary objective is to evaluate the impact of individualized SMS compared to standard SMS messages on the physical activity of patients with chronic inflammatory rheumatism or osteoporosis, included in a therapeutic education program.
Our hypothesis is that individualized SMS has a higher efficiency compared to standard SMS messages to increase the practice of physical activity in these patients.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Terkia MEDKOUR, PHD
- Phone Number: 0033158411507
- Email: terkia.medkour@aphp.fr
Study Locations
-
-
-
Paris, France, 75014
- Recruiting
- Cochin Hospital
-
Contact:
- TERKIA MEDKOUR, PHD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with osteoporosis or inflammatory rheumatism aged between 18 and 75 years, who participated in the patient's therapeutic education program
Description
Inclusion Criteria:
- patient age from 18 to 75 years
- Participated in therapeutic patient education program osteoporosis disease and inflammatory rheumatism disease
- Having given their written consent
- French speaking
- Possessing a telephone tool that accepts SMS
Exclusion Criteria:
- Patients unable to read SMS for practical, linguistic or cognitive reasons
- Patients who can not, for medical reasons or disability, set up 30 minutes of moderate physical activity (walking or other moderate activity) per day
- Having already participated in a similar study in inflammatory rheumatism or osteoporosis
- Already having the required level of physical activity: performing more than 30 minutes of moderate physical activity (walking or other moderate activity)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
patients receiving an individualized SMS
|
patients receiving a standard SMS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical activity
Time Frame: 1 YEAR
|
evaluate the percentage of patients reaching 30 minutes of moderate physical activity
|
1 YEAR
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 12, 2018
Primary Completion (Anticipated)
February 12, 2019
Study Completion (Anticipated)
January 12, 2020
Study Registration Dates
First Submitted
September 12, 2018
First Submitted That Met QC Criteria
September 12, 2018
First Posted (Actual)
September 13, 2018
Study Record Updates
Last Update Posted (Actual)
September 13, 2018
Last Update Submitted That Met QC Criteria
September 12, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 2016-A00580-51
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on to Help Improve the Quality of Life of Patients
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownTo Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRTTaiwan
-
Finnish Breast Cancer GroupCompletedImprove Quality of Life | Prevent Osteoporosis and Osteoporotic Fractures | Improve Weight Control, and Muscular and Cardiovascular Fitness | Help the Patients to Return to Working Life | Reduce the Risk of Breast Cancer Recurrence | Reduce All-cause Mortality in Patients With Primary Breast...Finland
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedThe Aim of This Research is to Investigate the Effect of Prolotherapy on Quality of Life and Painkiller Use in Patients With Chronic Knee PainTurkey
-
Rambam Health Care CampusUnknownto Evaluate the Performance of the TMS Thermometer and | Improve Its AlgorithmIsrael
-
AstraZenecaCompletedThe Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPIKorea, Republic of
-
University of British ColumbiaCompletedEfficacy of the Expert System's Ability to Help Detect Critical EventsCanada
-
Happy Nation SocietyCompleted
-
Cairo UniversityAin Shams University hospitalsUnknownthe Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ DamageEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia